J.P. Morgan reduces its stake in SINOPHARM (01099) by approximately 1.22 million shares, with a price of around HK$19.87 per share.
On February 18, J.P. Morgan reduced its holdings in China National Pharmaceutical Group Corporation (01099) by 1,221,708 shares, with each share priced at HK$19.8733.
According to the latest data from the Hong Kong Stock Exchange, on February 18th, J.P. Morgan reduced its holdings of SINOPHARM (01099) by 1,221,708 shares, with an average price of HK$19.8733 per share, for a total amount of approximately HK$24.2794 million. After the reduction, the latest number of shares held is approximately 107 million shares, and the latest shareholding ratio is 7.96%.
Related Articles
BlackRock increased its holdings of Beijing Airport (00694) by 13,400 shares, with a price of 2.858 Hong Kong dollars per share.
.png)
Thalys Medical Technology Group Corporation (603716.SH) plans to increase capital by 42.74 million yuan to Wuhan Huaji Yuan.
JP Morgan reduced its holdings in ZTE Corporation (00763) by approximately 1.6921 million shares, with a price of around HK$34.34 per share.
BlackRock increased its holdings of Beijing Airport (00694) by 13,400 shares, with a price of 2.858 Hong Kong dollars per share.
Thalys Medical Technology Group Corporation (603716.SH) plans to increase capital by 42.74 million yuan to Wuhan Huaji Yuan.
JP Morgan reduced its holdings in ZTE Corporation (00763) by approximately 1.6921 million shares, with a price of around HK$34.34 per share.
